×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Tyme Technologies files for mixed shelf offering of up to $250 mln
Reuters
Tyme Technologies Inc files for mixed shelf offering of up to $250 million - SEC filing Source text: [bit.ly/2eYTiIr] Further company coverage:.
3 months ago
Buying Tyme: Syros inks $190M merger, Flagship-backed financing to extend cash runway into 2025
Fierce Biotech
By merging with the floundering Tyme and tapping investors including Flagship, Syros has extended its cash runway out into 2025.
22 months ago
Syros Announces Closing of Merger with Tyme Technologies and Concurrent Private Placement
Business Wire
(NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced the closing of its merger with...
19 months ago
Syros closes $60M merger with Bedminster's TYME
NJBIZ
Stockholders of Syros Pharmaceuticals and Bedminster's TYME Technologies approved plans for a previously announced $60 million merger.
19 months ago
Executive Moves: Caryl Communications, Tyme Technologies and more
ROI-NJ
Executive Moves: Caryl Communications, Tyme Technologies and more · Lee Samuelson joins Saxum as general counsel and chief compliance officer;...
38 months ago
Syros and Tyme Technologies Announce Stockholder Approval of Merger
Business Wire
Syros and Tyme Technologies Announce Stockholder Approval of Merger ... CAMBRIDGE, Mass. & BEDMINSTER, N.J.--(BUSINESS WIRE)--Syros...
19 months ago
Will Tyme Technologies Continue to Surge Higher?
Yahoo
As of late, it has definitely been a great time to be an investor in Tyme Technologies.
62 months ago
TYME-18 Demonstrates Anti-Cancer Effect in New Preclinical Data Presented at AACR 2020
BioSpace
TYME-18 leverages unique metabolism of cancer to create an intra-tumoral treatment for inoperable cancers; Preclinical animal studies...
46 months ago
Tyme Technologies
The Pharma Letter
Tyme Technologies is an emerging biotechnology company developing cancer therapeutics that are intended to be broadly effective across tumor types and have...
51 months ago